StockData
Alumis Inc. logo

Alumis Inc. (ALMS) stock

ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.14−0.46 (-8.21%)

Close on Nov 16, 2026Market cap $665.30MP/E –Yield –

Alumis cash

Cash and short-term investments held at the end of each period.

Alumis's cash was $502.30M at Jun 30, 2026. For fiscal 2025 it was $308.50M, up 7.0% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$308.50M+7.0%
FY2024Dec 31, 2024$288.30M+475.6%
FY2023Dec 31, 2023$50.09M+85.8%
FY2022Dec 31, 2022$26.95M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$502.30M+3.3%
Q1 FY2026Mar 31, 2026$569.50M+172.9%
Q4 FY2025Dec 31, 2025$308.50M+7.0%
Q3 FY2025Sep 30, 2025$377.70M+4.4%
Q2 FY2025Jun 30, 2025$486.30M+132.1%
Q1 FY2025Mar 31, 2025$208.70M+86.2%
Q4 FY2024Dec 31, 2024$288.30M+475.6%
Q3 FY2024Sep 30, 2024$361.90M+571.0%
Q2 FY2024Jun 30, 2024$209.50M+163.3%
Q1 FY2024Mar 31, 2024$112.07M+315.8%
Q4 FY2023Dec 31, 2023$50.09M–
Q3 FY2023Sep 30, 2023$53.94M–
Q2 FY2023Jun 30, 2023$79.56M–
Q4 FY2022Dec 31, 2022$26.95M–

More Alumis figures

See a number that looks wrong?